Professional Seasonal Analysis for Trading

Atara Biotherapeutics, Inc. - Common Stock (ATRA)

Seasonality Analysis

Stocks 12 Years Analyzed

Atara Biotherapeutics, Inc. - Common Stock Annual Seasonality Statistics

5.50%
Avg Annual Return
48.5%
Avg Monthly Win Rate
6/12
Positive Months
12
Years Analyzed

Atara Biotherapeutics, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 1.20%
33%
Weak
February WORST -7.92%
25%
Very Weak
March 2.45%
42%
Weak
April -3.29%
42%
Weak
May -6.11%
45%
Weak
June 7.48%
64%
Strong
July 0.79%
55%
Moderate
August -3.00%
45%
Weak
September 4.05%
73%
Very Strong
October -0.85%
33%
Very Weak
November BEST 16.13%
83%
Very Strong
December -5.43%
42%
Weak

Atara Biotherapeutics, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
7.8
Historical Avg Position
42.96
Deviation
-35.16
Performance
Significantly Below Average

Atara Biotherapeutics, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ATRA with overlay patterns, custom date ranges, and more.

Create Free Account

Atara Biotherapeutics, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Atara Biotherapeutics, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for ATRA across multiple timeframes.

Create Free Account

About Atara Biotherapeutics, Inc. - Common Stock (ATRA) Seasonality

Atara Biotherapeutics, Inc. - Common Stock (ATRA) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Atara Biotherapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Atara Biotherapeutics, Inc. - Common Stock is historically November, with an average return of 16.13% and a win rate of 83%. Conversely, February tends to be the weakest month, averaging -7.92% return.

Looking at the full calendar year, Atara Biotherapeutics, Inc. - Common Stock has an average annual return of 5.50% with an overall monthly win rate of 48.5%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Atara Biotherapeutics, Inc. - Common Stock has a consistency score of 39.7 (Poor), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Atara Biotherapeutics, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Atara Biotherapeutics, Inc. - Common Stock (ATRA)?

Historically, November has been the best month for Atara Biotherapeutics, Inc. - Common Stock, with an average return of 16.13% and a win rate of 83%. However, past performance does not guarantee future results.

What is the worst month for Atara Biotherapeutics, Inc. - Common Stock (ATRA)?

Based on historical data, February has been the weakest month for Atara Biotherapeutics, Inc. - Common Stock, with an average return of -7.92%. This is a historical observation and does not guarantee future results.

How reliable is ATRA seasonality data?

The seasonality analysis for Atara Biotherapeutics, Inc. - Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Atara Biotherapeutics, Inc. - Common Stock seasonality in my trading?

Use Atara Biotherapeutics, Inc. - Common Stock (ATRA) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.